Immune response to genital chlamydial infection and influence of Chlamydia pneumoniae (TWAR) antibodies

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S Osser, K Persson

Abstract

Chlamydial IgG antibodies at a titre of at least 32 were found to occur at approximately the same frequency (76-88%) in three groups of patients who had been treated for genital chlamydial infection. Twenty-four patients who had recovered from acute salpingitis, however, had a higher geometric mean titre (GMT; 176) than 59 pregnant women (GMT 44) or 61 patients with uncomplicated genital chlamydial infection (GMT 57). The chlamydial antibody titres thus seemed to reflect the severity of inflammatory involvement. Antibodies to the new species Chlamydia pneumoniae (previously known as Chlamydia TWAR), did not influence the frequency or titre of antibodies to Chlamydia trachomatis, arguing against the possibility of cross-reactivity or shared antigens. There was assumed to be no cross-immunity, since patients with Chlamydia trachomatis infection did not have a lower frequency of antibodies to Chlamydia pneumoniae.

References

Jun 1, 1979·Fertility and Sterility·R PunnonenO Meurman
Feb 1, 1979·The British Journal of Venereal Diseases·J D TreharneS Darougar
Oct 1, 1977·Journal of Clinical Microbiology·K T Ripa, P A Mårdh
Jul 17, 1986·The New England Journal of Medicine·J T GraystonJ Altman
Dec 1, 1984·International Journal of Epidemiology·P BurneyR Chamberlain
Dec 1, 1980·American Journal of Obstetrics and Gynecology·J Paavonen

❮ Previous
Next ❯

Citations

Dec 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H M FreidankB Jung
Jan 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·B HerrmannP A Mårdh
Apr 1, 1991·Genitourinary Medicine·L O SvenssonS E Olsson
Feb 1, 1996·British Journal of Obstetrics and Gynaecology·S Osser, K Persson
Jan 1, 1996·Scandinavian Journal of Infectious Diseases·E BjornssonG Boman
Jul 17, 1998·Journal of Clinical Microbiology·R P VerkooyenH A Verbrugh
Mar 1, 1994·Journal of Clinical Microbiology·Y IijimaA Matsumoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Baillière's Clinical Obstetrics and Gynaecology
E Pixley, M Coppleson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
K Stenberg, P A Mårdh
The Journal of Antimicrobial Chemotherapy
S S Witkin, W J Ledger
© 2022 Meta ULC. All rights reserved